10:00-14:30 | Joint Meeting SIU / HUA: Bench to Bedside (B2B) -Prostate Cancer
Chairmen: Iraklis Poulias , Athanasios Papatsoris |
HALL A |
10:00-10:10 | Introduction & Welcome by the Chairmen of B2B meeting
Iraklis Poulias President of H.U.A. Athanasios Papatsoris, General Secretary of H.U.A. |
|
10:10-12:30 | Localized and hormone sensitive PCa
Moderators: Jean de la Rosette, Ioannis Varkarakis |
|
10:10-10:30 | Clinical and Molecular variability of Prostate Cancer
Dr Selcuk Guven, Turkey |
|
10:30-10:50 | The role of lymphadenectomy in Prostate Cancer & novel achievement in Robotic Prostatectomy
Dr Paolo Gontero, Italy |
|
10:50-11:10 | Novel achievements of robotic radical prostatectomy
Markos Karavitakis , Greece |
|
11:10-11:30 | Management of biochemical and loco-regional recurrence
Ioannis Varkarakis, Greece |
|
11:30-11:50 | The role of LHRH antagonists
Dr Selcuk Guven, Turkey |
|
11:50-12:10 | Novel antiandrogens in PCa M0
Dr Paolo Gontero, Italy |
|
12:10-12:30 | Chemo-hormone treatment in hormone sensitive disease
Georgios Moutzouris, Greece |
|
12:30-13:30 | Break & Light Lunch | |
13:30-14:30 |
Castration Resistant PCa Moderators: Alkiviadis Grigorakis, Ioannis Gkialas |
|
13:30-13:50 |
Diagnosis and management of CRPC M0 Georgios Papadopoulos, Greece |
|
13:50-14:10 |
Sequencing of medications in CRPC M+ Theodoros Kalogeropoulos, Greece |
|
14:10-14:30 |
Non urological considerations in CRPC Dr Paolo Gontero, Italy |